105 related articles for article (PubMed ID: 28641566)
1. Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?
Topuk S; Akyuva Y; Karaaslan N; Mutlu CA; Yilmaz I; Isyar M; Sirin DY; Akkaya S; Özbek H; Mahirogullari M
Curr Pharm Biotechnol; 2017; 18(6):516-522. PubMed ID: 28641566
[TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of Drug-Loaded Hydrogels for Application in Osteosarcoma Treatment.
Ali Gumustas S; Isyar M; Topuk S; Yilmaz I; Oznam K; Onay T; Ofluoglu O; Mahirogullari M
Curr Pharm Biotechnol; 2016; 17(10):866-72. PubMed ID: 27194356
[TBL] [Abstract][Full Text] [Related]
3. Mannose-conjugated layered double hydroxide nanocomposite for targeted siRNA delivery to enhance cancer therapy.
Li L; Zhang R; Gu W; Xu ZP
Nanomedicine; 2018 Oct; 14(7):2355-2364. PubMed ID: 28647589
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of VEGF-siRNA mediated by adenovirus on osteosarcoma-bearing nude mice.
Gao YS; Mei J; Tong TL; Hu M; Xue HM; Cai XS
Cancer Biother Radiopharm; 2009 Apr; 24(2):243-7. PubMed ID: 19409047
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma.
Sueyoshi T; Jono H; Shinriki S; Ota K; Ota T; Tasaki M; Atsuyama E; Yakushiji T; Ueda M; Obayashi K; Mizuta H; Ando Y
Cancer Lett; 2012 Mar; 316(1):23-30. PubMed ID: 22099874
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
[TBL] [Abstract][Full Text] [Related]
7. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapies in bone sarcomas: current approach and future directions.
Yarber JL; Agulnik M
Expert Opin Investig Drugs; 2011 Jul; 20(7):973-9. PubMed ID: 21510829
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and recombinant plasmid pHSP70-Plk1-shRNA by bacterial magnetosomes for osteosarcoma therapy.
Cheng L; Ke Y; Yu S; Jing J
Int J Nanomedicine; 2016; 11():5277-5286. PubMed ID: 27822032
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs for osteosarcoma in the mouse: a meta-analysis.
Chang J; Yao M; Li Y; Zhao D; Hu S; Cui X; Liu G; Shi Q; Wang Y; Yang Y
Oncotarget; 2016 Dec; 7(51):85650-85674. PubMed ID: 27852052
[TBL] [Abstract][Full Text] [Related]
11. In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy.
Yu L; Fan G; Wang Q; Zhu Y; Zhu H; Chang J; Wang Z; Zhan S; Hua X; She D; Huang J; Wang Y; Zhao J; Zhang CY; Chen X; Zhou G
Cell Death Dis; 2023 Sep; 14(9):626. PubMed ID: 37739958
[TBL] [Abstract][Full Text] [Related]
12. Emerging RNA-based drugs: siRNAs, microRNAs and derivates.
Pereira TC; Lopes-Cendes I
Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):217-32. PubMed ID: 22697266
[TBL] [Abstract][Full Text] [Related]
13. shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells.
Chen P; Gu WL; Gong MZ; Wang J; Li DQ
Cancer Gene Ther; 2017 Aug; 24(8):325-332. PubMed ID: 28799566
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Smart and Controllable Systems for Gene Delivery.
Mostaghaci B
Curr Gene Ther; 2017; 17(2):71-72. PubMed ID: 28524008
[No Abstract] [Full Text] [Related]
15. Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies.
Pereira-Silva M; Alvarez-Lorenzo C; Concheiro A; Santos AC; Veiga F; Figueiras A
Eur J Pharm Biopharm; 2020 Mar; 148():88-106. PubMed ID: 31958514
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
[TBL] [Abstract][Full Text] [Related]
17. Silencing of Kv1.5 Gene Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells.
Wu J; Chen Z; Liu Q; Zeng W; Wu X; Lin B
Int J Mol Sci; 2015 Nov; 16(11):26914-26. PubMed ID: 26569226
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504
[TBL] [Abstract][Full Text] [Related]
19. Making gene therapy for osteosarcoma a reality.
Broadhead ML; Clark JC; Choong PF; Dass CR
Expert Rev Anticancer Ther; 2010 Apr; 10(4):477-80. PubMed ID: 20397911
[No Abstract] [Full Text] [Related]
20. Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.
Morrow JJ; Khanna C
Crit Rev Oncog; 2015; 20(3-4):173-97. PubMed ID: 26349415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
